Stock Events

Stock Events

China Pharma 

$1.24
53
+$0.24+24.45% Thursday 20:01

Statistics

Day High
1.46
Day Low
0.86
52W High
2.35
52W Low
0.52
Volume
1,924,531
Avg. Volume
-
Mkt Cap
6.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18MayExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.2
-0.13
-0.07
0
Expected EPS
0
Actual EPS
-0.1988

Financials

-104.57%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
9.06MRevenue
-9.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CPHI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. is a direct competitor in the vaccine and biopharmaceutical sector, focusing on research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
Zai Lab Limited
ZLAB
Mkt Cap2.09B
Zai Lab Limited is a biopharmaceutical company that competes with China Pharma by focusing on bringing transformative medicines for cancer, infectious, and autoimmune diseases to the market in China.
HUTCHMED (China) Limited
HCM
Mkt Cap2.26B
Hutchison China MediTech Limited, known as Chi-Med, is a competitor in the innovation, development, and commercialization of targeted therapeutics and immunotherapies for oncology and autoimmune diseases.
China Pharma
CPHI
Mkt Cap21.48M
China Pharma Holdings, Inc. itself, included for reference.
GSK
GSK
Mkt Cap101.2B
GlaxoSmithKline plc, though a British company, competes globally, including in China, in pharmaceuticals and vaccines, covering a broad range of diseases that China Pharma also targets.
Novartis
NVS
Mkt Cap278.64B
Novartis AG, a Swiss multinational pharmaceutical company, competes in various therapeutic areas including those relevant to China Pharma's business, with a strong presence in the Chinese market.
Pfizer
PFE
Mkt Cap146.36B
Pfizer Inc., an American multinational pharmaceutical corporation, competes directly with China Pharma in the development and marketing of medicines and vaccines for a wide range of medical disciplines.

About

There is no Profile data available for XQJ.SG.
Show more...
CEO
Ms. Zhilin Li
Employees
224
Country
United States
ISIN
US16941T4013

Listings

MU
DE
XQJ.MU
XASE
US
CPHI
STU
DE
XQJ.STU
BOATS
BOATS
CPHI.BOATS

0 Comments

Share your thoughts

FAQ

What is China Pharma stock price today?▼
The current price of CPHI is $1.24 USD — it has increased by +24.45% in the past 24 hours. Watch China Pharma stock price performance more closely on the chart.
What is China Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange China Pharma stocks are traded under the ticker CPHI.
Is China Pharma stock price growing?▼
CPHI stock has risen by +133.96% compared to the previous week, the month change is a +91.06% rise, over the last year China Pharma has showed a -47.23% decrease.
What is China Pharma market cap?▼
Today China Pharma has the market capitalization of 6.23M
What were China Pharma earnings last quarter?▼
CPHI earnings for the last quarter are -0.2 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is China Pharma revenue for the last year?▼
China Pharma revenue for the last year amounts to 9.06M USD.
What is China Pharma net income for the last year?▼
CPHI net income for the last year is -9.47M USD.
How many employees does China Pharma have?▼
As of May 15, 2026, the company has 224 employees.
In which sector is China Pharma located?▼
China Pharma operates in the Health & Wellness sector.
When did China Pharma complete a stock split?▼
The last stock split for China Pharma was on April 15, 2025 with a ratio of 1:10.
Where is China Pharma headquartered?▼
China Pharma is headquartered in Haikou, United States.